Sinopharm Group Co Financial Overview
Sinopharm Group Co's market cap is currently HK$61.95B. The company's EPS TTM is HK$0.6496731251; its P/E ratio is 8.43; and it has a dividend yield of 3.72%. Sinopharm Group Co is scheduled to report earnings on October 26, 2025, and the estimated EPS forecast is HK$1.26. See an overview of income statement, balance sheet, and cash flow financials.
